Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT02767388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02767388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Lead sponsor
University of Nebraska
Phase
Observational
Overall status
Completed
Start date
September 1, 2016
Completion date
March 15, 2018
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, effects of chemotherapy, mild cognitive impairment, multiple myeloma, myelodysplastic syndrome, non-hodgkin lymphoma